Adrenal Corticomedullary Mixed Tumor Associated With the FGFR4-G388R Variant

Abstract Adrenal corticomedullary mixed tumors (CMMTs) are extremely rare; with only 20 cases being reported to date, the pathogenesis has remained elusive. A 31-year-old woman developed gestational hypertension with psychiatric disturbances persistent to postpartum and was diagnosed with pheochromocytoma, for which adrenalectomy was performed. Histological findings showed mixed adrenocortical adenoma and pheochromocytoma. Double immunostaining of inhibin and INSM1 (insulinoma-associated protein 1) showed that the 2 tumor components had distinct functional properties. Exome analysis of peripheral leukocytes and tumor (singular, as anatomically it is only 1 mass) revealed a homozygous germline FGFR4-G388R variant. As a readout of the variant, serine phosphorylation of signal transducer and activator of transcription 3 (STAT3) was detected only in the nucleus of adrenocortical adenoma component but not in the pheochromocytoma component. No tyrosine phosphorylation of STAT3 was detected. We report a case of CMMT with the germline FGFR4-G388R variant. Although additional studies are required, our immunohistochemical analysis suggests that the variant may play a role in the development of the adrenocortical component within the pheochromocytoma, leading to CMMT.

[1]  S. Bornstein,et al.  Isolation and characterization of adrenocortical progenitors involved in the adaptation to stress , 2018, Proceedings of the National Academy of Sciences.

[2]  Yingxiao Wang,et al.  Pathological cyclic strain promotes proliferation of vascular smooth muscle cells via the ACTH/ERK/STAT3 pathway , 2018, Journal of cellular biochemistry.

[3]  J. Bertherat,et al.  Genetics of tumors of the adrenal cortex. , 2017, Endocrine-related cancer.

[4]  R. Lloyd,et al.  WHO classification of tumours of endocrine organs , 2017 .

[5]  Hongting Zheng,et al.  Corticomedullary mixed tumour resembling a small adrenal gland-involvement of cancer stem cells: case report , 2017, BMC Endocrine Disorders.

[6]  A. Ullrich,et al.  Germline variant FGFR4  p.G388R exposes a membrane-proximal STAT3 binding site , 2015, Nature.

[7]  H. Sasano,et al.  Development of monoclonal antibodies against human CYP11B1 and CYP11B2 , 2014, Molecular and Cellular Endocrinology.

[8]  H. Sasano,et al.  Characterization of steroidogenic enzyme expression in aldosterone-producing adenoma: a comparison with various human adrenal tumors. , 2013, Endocrine journal.

[9]  S. Aubert,et al.  Corticomedullary mixed tumor of the adrenal gland—a clinical and pathological chameleon: case report and review of literature , 2013, Updates in Surgery.

[10]  G. Karayannopoulou,et al.  Mixed corticomedullary adrenal carcinoma , 2013, Surgery Today.

[11]  Y. Homma,et al.  Dopamine‐secreting corticomedullary mixed tumor of the adrenal gland , 2012, International journal of urology : official journal of the Japanese Urological Association.

[12]  V. Livolsi,et al.  Mixed corticomedullary carcinoma of the adrenal gland: a case report. , 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[13]  T. Tateno,et al.  The FGFR4-G388R Polymorphism Promotes Mitochondrial STAT3 Serine Phosphorylation to Facilitate Pituitary Growth Hormone Cell Tumorigenesis , 2011, PLoS genetics.

[14]  P. Chu,et al.  Mixed cortical adenoma and composite pheochromocytoma-ganglioneuroma: an unusual corticomedullary tumor of the adrenal gland. , 2011, Annals of diagnostic pathology.

[15]  M. Mokni,et al.  Corticomedullary mixed tumor of the adrenal gland. , 2009, Annales d'endocrinologie.

[16]  Karel Pacak,et al.  Phaeochromocytoma , 2005, The Lancet.

[17]  L. Thompson,et al.  Corticomedullary mixed tumor of the adrenal gland. , 2001, Annals of diagnostic pathology.